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S6 Diabetic NephropathyResults: HFHS diet led to vacuolization and thyroidisation of the renal tu-
bules. Glucose caused mitochondrial fragmentation and cellular apoptosis
in HK2 cells. Autophagy was activated in glucose-treated cells as evidenced
by the enhanced LC3B-II expression and autophagosome formation. When
autophagy was inhibited, either by the inhibitor, 3-MA, or by siATG5, tubular
cells were more susceptible to glucose-induced mitochondrial fragmentation
and cellular apoptosis. When MFN1 or MFN2 was knockdown, mitochondria
became more fragmented and autophagy was activated. When FIS1 was
silenced, mitochondria were not fragmented and the expressions of LC3B-
II, p62 and BECN1 remained unchanged.
Conclusion: Our results characterized the pathology of diabetic tubulopathy
and suggested that glucose leads to mitochondrial fragmentation and
cellular apoptosis in renal tubules. We also offered evidence that autophagy
protects mitochondrial from fragmentation in renal tubules.http://dx.doi.org/10.1016/j.hkjn.2015.08.020
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Protective Effect of Tangshen Formula on Renal Inflammation in Type 2
Diabetes
Tingting Zhao, Sifan Sun, Ping Li
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Chaoyang, Beijing, China
Objective: Tangshen Formula (TSF), a traditional Chinese medicine, had
been reported to have beneficial effects on diabetic nephropathy (DN),
but its action mechanism is still unclear. The study was designed to elucidate
the potential mechanism of TSF in treating DN.
Methods: Type 2 DN rat models were established by high-fat diet-fed and
low-dose-streptozotocin injection. The rats were treated with or without
TSF by gavage for 20 weeks and examined by 24h-albuminuria, histology,
immunohistochemistry, molecular analyses.
Results: The results showed that TSF treatment significantly inhibited uri-
nary excretion of albumin, and attenuated renal histological injuries in
the rats. TSF treatment also inhibited renal inflammation which was associ-
ated with inactivation of NF-kB signaling. In addition, TSF treatment also
suppressed expressions of fibronectin, collagen I, and collagen IV.
Conclusion: The present study revealed that TSF might attenuate renal
inflammation of type 2 DN by inhibiting NF-kB signaling pathway.
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Objective: In diabetic nephropathy, it has been proven lipotoxicity is an
important pathological mechanism of progressive tubulointerstitial injury.
Electron transport flavoprotein (ETF) is an electron acceptor in fatty acid
b oxidation, which is composed by a and b subunits. Our previous studies
have found ETFb point mutations in conserved sequences by renal cortex
proteome in diabetic nephropathy. In this study, the expression and distri-
bution of ETFb and its role in diabetic kidney damage were explored to pro-
vide new ideas for further insight into the pathogenesis of diabetic
nephropathy.
Methods:Expression of ETFb in kidneywasdetectedbyWestern blot and immu-
nohistochemistry in amodel of spontaneous type 2 diabetic OLETF rats. The ef-
fects of ETFb at low expression on fatty acid-induced apoptosis by knockingdown the genewere detected in NRK 52E cells. Apoptosis and related apoptosis
pathways induced by fatty acid or knock down of ETFb combined with fatty
acids stimulate were compared to analyze the influence of ETFb on lipotoxic
apoptosis.
Results: Decreased ETFb expression occurred only in 56-week-old rats which
was correlated with massive proteinuria and severe tubular damage. We
found increased ROS generation, decreased mitochondrial membrane poten-
tial, increased expression of BAX, and decreased Bcl-2, increased Cleaved
caspase-3, and a lot of apoptotic cells in NRK 52E cells induced by palmitate.
After ETFb gene was knocked out, the above change by PA stimulation in
mitochondrial apoptosis pathway was furtherly aggravated.
Conclusion: The expression of ETFb in kidney cortex was significantly
decreased with the progression of renal injury in diabetic nephropathy
rats. Knock down of ETFb under palmitate stimulation can significantly in-
crease apoptosis rate. Thus, we speculate decreased ETFb expression may
be involved in renal tubular epithelial cells apoptosis and the progression
of diabetic nephropathy.http://dx.doi.org/10.1016/j.hkjn.2015.08.022
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Haematuria and Outcomes in Patients with Diabetic Chronic Kidney
Disease
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Objective: Microscopic haematuria (denoted as haematuria) is considered a
risk factor for end-stage renal disease (ESRD) in glomerulonephritis. Haema-
turia is not infrequent in patients with diabetic chronic kidney disease (CKD)
and is associated with albuminuria and the duration of diabetes. However,
the clinical significance of haematuria in patients with diabetic CKD has
been rarely studied.
Methods:We included 1958 patients with type 2 diabetes and CKD stages 1e5
from nephrology outpatient department. They were divided into 3 groups ac-
cording to haematuria in 3 consecutive urinalyses: no haematuria (0e2 red
blood cells [RBCs]/high-power field [hpf]  2 times), mild haematuria (2e5
RBCs/hpf 2 times), and moderate haematuria (5e10 RBCs/hpf 2 times).
Results: The average estimated glomerular filtration rate was 24.5
(12.0e40.0) ml/min/1.73 m2 and the average urine protein-to-creatinine ra-
tio (UPCR) was 1448 (471e3622) mg/g. Among 102 patients received biopsy,
42 patients (41.2%) had biopsy-proven diabetic nephropathy. We observed
that haematuria was associated with age, UPCR, duration of diabetes,
mean blood pressure, albumin, glycated haemoglobin, and C-reactive pro-
tein. The hazard ratio (HR) of moderate haematuria for ESRD was 1.39
(95% confidence interval [CI]: 1.10e1.76, P < 0.001). The odds ratios (ORs)
of moderate haematuria for rapid renal progression wad 1.81 (95% CI:
1.29e2.53, P < 0.001). Moreover, the HRs of mild haematuria and moderate
haematuria for mortality were 1.43 (95% CI: 1.12e1.84, PZ 0.005) and 1.73
(95% CI: 1.27e2.36, P < 0.001), respectively. In the subgroup analysis, we
observed that the association between haematuria and ESRD was more
prominent in patients with CKD stages 1e3 or UPCR <500 mg/g.
Conclusion: Microscopic haematuria in patients with diabetic CKD is associ-
ated with risks for ESRD and mortality.http://dx.doi.org/10.1016/j.hkjn.2015.08.023
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Objective: Research the distribution of syndrome differentiation in Tradi-
tional Chinese Medicine (TCM) on diabetic kidney disease (DKD) and its rela-
tionship with pathological stage of DKD.
Diabetic Nephropathy S7Methods: Bring into the DKD patients through pathological diagnosis which
have more than one year disease course, to classify by the Tervaet criterion
of pathological stage of DKD, to differentiate the syndrome differentiation
in TCM by collecting clinical data, and have a statistical processing at last.
Results: We collected 353 DKD patients meeting the criterion in total, clas-
sified by the pathological stage criterion of DKD, among them there were 52
patients with phase I, 90 patients with phase IIa, 29 patients with phase
IIb,141 patients with phase III, 41 patients with phase IV. About syndrome
differentiation, there were 13 patients with Yin-Xu-Zao-Re type, there
were 151 patients with Qi-Yin-Liang-Xu type, there were 140 patients with
Pi-Shen-Qi-Xu type, there were 49 patients with Yin-Yang-Liang-Xu type,
there were 19 patients with Han-Shi type, there were 68 patients with Shi-
Re type, there were 212 patients with Yu-Xue type, there were 54 patients
with Tan-Yu type. In the patients with Yin-Xu-Zao-Re type, the renal inter-
stitial inflammation was more serious than other typs. In the patients with
Pi-Shen-Qi-Xu type, the glomerular segmental sclerosis, nodular changes,
and fibrinoid exudation were more serious than other groups. In the patients
with Yu-Xue syndrome differentiation, interstitial fibrosis and tubular atro-
phy (IFTA), interstitial inflammation, hyaline degeneration, angiosclerosis,
and fibrinoid exudation were more serious than other types significantly.
Multivariate COX analysis showed that syndrome differentiation were inde-
pendent risk factors for renal prognosis.
Conclusion: Among the syndrome differentiation of DKD, Qi-Yin-Liang-Xu
type and Yu-Xue type were more frequently than other tyes. The result
showed that syndrome differentiation was correlated significantly with path-
ological stage of DKD, Yin-Yang-Liang-Xu type and Tan-Yu type were inde-
pendent risk factors for renal prognosis in DKD.http://dx.doi.org/10.1016/j.hkjn.2015.08.0240096
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Rat Model via Upregulating Smad7
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Objective: Diabetic nephropathy (DN) is one of the most severe microvascular
complications of diabetes. Recently, Berberine (BBR) has the beneficial effects
to diabetes. The aim of this study is to observe the renoprotective effect and
mechanisms of berberine in a type 2 diabetes nephropathy on rat.
Methods: Twenty seven male Wistar rats (8-wk old, 200e250 g) randomly
divided into 9 rats in normal control and 18 rats in diabetic groups. Diabetic
rats were fedwith a high-fat diet (consisting of 50% carbohydrate, 12% protein,
and 38% fat) for 5 wk, followed by intraperitoneal injection with a single low-
dose of streptozotocin (STZ, 25 mg/kg) after 12-h fasting. The normal control
rats were fed with a standard chow diet. Diabetic rats were randomly divided
into two subgroups: vehicle treated and BBR treated (nZ 9 each). Rats were
housed individually inmetabolic cages for 24-h urinary collection at 4-wk inter-
vals. Ratswere sacrificed 20weeks later.Wedetected the kidneyweight index,
24 h urine protein, morphology study, inflammation and fibrosis markers, such
as IkBa, TGFb1, TbRI and Smad7 by realtime-PCR and Western Blot.
Results: (1) Comparedwith normal rats, the diabetic rats showed higher kidney
weight index and 24h urine protein, berberine treatment decreased kidney
weight index and 24 h urine protein. (2) BBR treatment inhibited histological
injury including deposition of extracellular matrix, thickening of glomerular
basement membrane, and tubular atrophy of DN rats. (3) DN rats showed
decreased Smad7 mRNA and protein expression (P < 0.01), increased
TGFb1mRNA (P < 0.05) and TbRI protein expression (P < 0.05); however, BBR
treatment down-regulated TGFb1, TbRI level (P < 0.05), up-regulated Smad7,
IkBa level (P < 0.05).
Conclusion: Berberine has renoprotective effect on a type 2 diabetic rat
model. The mechanism might suppress inflammation and fibrosis via upregu-
lating expression of Smad7.http://dx.doi.org/10.1016/j.hkjn.2015.08.025
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Effects of Tangshen Formula on Dihydropteridine Reductase
Transcription
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Objectives: Tangshen Formula (TSF) is a Chinese herbal medicine used for
DN treatment. In the current study, we aimed to identify the core regulatory
region of QDPR gene promoter. We also studied whether the Tangshen For-
mula could up-regulate QDPR promoter activity in vitro study and to investi-
gate the Tangshen Formula’s mechanism at molecular level.
Results: Identification of core regulatory region in QDPR gene promoter: as
compared with 2092 w 1 fragment, the relative fluorescence intensity of
the deleted fragment 529 w 116 reduced to 1% (P < 0.01), the fragment
which contained 529w 1 kept 64% (P< 0.05). The relative fluorescence in-
tensity of those deleted fragments 529w 429, 428w 250 and 141w
116 were increased (P < 0.01), and the deleted fragment 249w 142 was
decreased (P< 0.05).QDPR gene promoter couldbe recognized as TangshenFor-
mula’s drug targets: LDH experimental data showed that: the suitable Tangshen
Formula’s concentration in cell experiment were 800 g/ml or less. Results
showed that: Tangshen Formula can improve QDPR gene promoter activity.
Tangshen Formula can improve D5’/pGL3, D3/pGL3, D4/pGL3 three recombi-
nant plasmids activity. But comparing with no drug treated group, drug treated
group is no effect on D1-4/pGL3, D1/pGL3, D2/pGL3’s activity (P> 0.01).
Conclusion: Rat QDPR core regulatory region might locate between 529 and
116 where existing putative negative and positive regulatory elements, espe-
cially, existing several Sp1 binding sites. There may be a potential Sp1 binding
sites at 141w 116 which could inhibit the transcriptional activity of the
promoter.
